Thursday May 25th 2017

Archive for March, 2012

What’s up doc?

What’s up doc?

“I’m like Forrest Gump, okay?” Mark Docherty said before launching into yet another unbelievable story. In his 50 years, the Regina native has travelled around the world, opened a music venue, organized the Bloody Sunday march on his university practicum in Northern [Read More]

Doctors talk about controversial treatment for MS (Video)

Doctors talk about controversial treatment for MS (Video)

Both supporters and skeptics of an alternative treatment for the disease multiple sclerosis are gathering in the Bay Area. Research into the technique is drawing attention from around the world. Carol Schumacher says she is finally able to walk without a cane and she [Read More]

Unblocking veins in M.S.: New U.S. study supports Zamboni’s CCSVI theory

Unblocking veins in M.S.: New U.S. study supports Zamboni’s CCSVI theory

Eight months ago, on the advice of Canadian Institutes of Health Research (CIHR) president, Alain Beaudet, federal Health Minister Leona Aglukkaq announced funding for an early (phase 1/2) clinical study of venoplasty (the so-called “ liberation treatment ”) for chronic [Read More]

 Page 1 of 5  1  2  3  4  5 »

Latest Topics

Study finds variations among hospitals in transitioning stroke patients from treatment to comfort care

Study finds variations among hospitals in transitioning stroke patients from treatment to comfort care

Hospitals vary widely in how often they transition people with strokes from active treatment to comfort or hospice care [Read More]

Roche investigating case of patient illness after taking MS drug

Roche investigating case of patient illness after taking MS drug

ZURICH (Reuters) - A person in Germany treated with Roche ’s new multiple sclerosis drug Ocrevus has been diagnosed [Read More]

MS Study Alert: Share Your Thoughts About MS Research

MS Study Alert: Share Your Thoughts About MS Research

/About-the-Society/News/MS-Study-Alert-Share-Your-Thoughts-About-MS-Resea [Read More]

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

UK-based specialist pharmaceutical firm Mallinckrodt has begun patient enrolment in the Phase IV OPTIONS clinical trial [Read More]

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

/About-the-Society/News/First-Results-Announced-from-Second-Phase-III-Tria [Read More]